Loss of nuclear activity of the FBXO7 protein in patients with parkinsonian-pyramidal syndrome (PARK15)

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Zhao, Tianna ^a   de Graaff, Esther ^a   Breedveld, Guido J ^a   Loda, Agnese ^a   Severijnen, Lies Anne ^a   Wouters, Cokkie H ^a   Verheijen, Frans W ^a   Dekker, Marieke C J ^b   Montagna, Pasquale ^c   Willemsen, Rob ^a   Oostra, Ben A ^a   Bonifati, Vincenzo ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

F BOX PROTEIN; F BOX PROTEIN 7; F BOX PROTEIN 7 ISOFORM 1; F BOX PROTEIN 7 ISOFORM 2; PROFILIN; UNCLASSIFIED DRUG; FBXO7 PROTEIN, HUMAN; ISOPROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL NUCLEUS; CELL STRAIN HEK293; CELLULAR DISTRIBUTION; CEREBELLUM; CONTROLLED STUDY; CYTOPLASM; DEGENERATIVE DISEASE; F BOX ONLY PROTEIN 7 GENE; GENE; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MISSENSE MUTATION; MOUSE; NETHERLANDS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONIAN PYRAMIDAL SYNDROME; PROTEIN EXPRESSION; PROTEIN STABILITY; SKIN FIBROBLAST; SUBSTANTIA NIGRA; AGED; ANIMAL; BRAIN; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; INTRACELLULAR SPACE; MALE; METABOLISM; MUTATION; NERVE CELL; NERVE CELL NETWORK; PARKINSONISM; PATHOLOGY; PROTEIN TRANSPORT;

PARKINSONIA;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN; CELL LINE; CELL NUCLEUS; F-BOX PROTEINS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; INTRACELLULAR SPACE; MALE; MICE; MUTATION; NERVE NET; NEURONS; PARKINSONIAN DISORDERS; PROTEIN ISOFORMS; PROTEIN TRANSPORT;

EID: 79951825470     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0016983     Document Type: Article

References (23)

1. Tolosa E, Wenning G, Poewe W, (2006) The diagnosis of Parkinson's disease. Lancet Neurol 5: 75-86.
2. Gupta A, Dawson VL, Dawson TM, (2008) What causes cell death in Parkinson's disease? Ann Neurol 64 (Suppl 2): S3-15.
3. Gasser T, (2009) Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 11: e22.
4. Bonifati V, (2007) Genetics of parkinsonism. Parkinsonism Relat Disord 13(Suppl 3): S233-S241.
5. Healy DG, Falchi M, O'Sullivan SS, Bonifati V, Durr A, et al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study. Lancet Neurol 7: 583-590.
6. Ahlskog JE, (2009) Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. Parkinsonism Relat Disord 15: 721-727.
7. Bonifati V, (2010) PARK7, DJ1. In: Kompoliti K, Verhagen Metman L, editors. Encyclopedia of Movement Disorders 3 Oxford Academic Press: 392-395.
8. Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, et al. (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38: 1184-1191.
9. Gitler AD, Chesi A, Geddie ML, Strathearn KE, Hamamichi S, et al. (2009) Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat Genet 41: 308-315.
10. Di Fonzo A, Dekker MC, Montagna P, Baruzzi A, Yonova EH, et al. (2009) FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome. Neurology 72: 240-245.
11. Shojaee S, Sina F, Banihosseini SS, Kazemi MH, Kalhor R, et al. (2008) Genome-wide linkage analysis of a Parkinsonian-pyramidal syndrome pedigree by 500 K SNP arrays. Am J Hum Genet 82: 1375-1384.
12. Cenciarelli C, Chiaur DS, Guardavaccaro D, Parks W, Vidal M, et al. (1999) Identification of a family of human F-box proteins. Curr Biol 9: 1177-1179.
13. Winston JT, Koepp DM, Zhu C, Elledge SJ, Harper JW, (1999) A family of mammalian F-box proteins. Curr Biol 9: 1180-1182.
14. Ilyin GP, Rialland M, Pigeon C, Guguen-Guillouzo C, (2000) cDNA cloning and expression analysis of new members of the mammalian F-box protein family. Genomics 67: 40-47.
15. Ho MS, Ou C, Chan YR, Chien CT, Pi H, (2008) The utility F-box for protein destruction. Cell Mol Life Sci 65: 1977-2000.
16. Kirk R, Laman H, Knowles PP, Murray-Rust J, Lomonosov M, et al. (2008) Structure of a Conserved Dimerization Domain within the F-box Protein Fbxo7 and the PI31 Proteasome Inhibitor. J Biol Chem 283: 22325-22335.
17. Hsu JM, Lee YC, Yu CT, Huang CY, (2004) Fbx7 functions in the SCF complex regulating Cdk1-cyclin B-phosphorylated hepatoma up-regulated protein (HURP) proteolysis by a proline-rich region. J Biol Chem 279: 32592-32602.
18. Chang YF, Cheng CM, Chang LK, Jong YJ, Yuo CY, (2006) The F-box protein Fbxo7 interacts with human inhibitor of apoptosis protein cIAP1 and promotes cIAP1 ubiquitination. Biochem Biophys Res Commun 342: 1022-1026.
19. Laman H, Funes JM, Ye H, Henderson S, Galinanes-Garcia L, et al. (2005) Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6. Embo J 24: 3104-3116.
20. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE, (2004) Nonsense-mediated decay approaches the clinic. Nat Genet 36: 801-808.
21. Boulikas T, (1994) Putative nuclear localization signals (NLS) in protein transcription factors. J Cell Biochem 55: 32-58.
22. French CA, Tambini CE, Thacker J, (2003) Identification of functional domains in the RAD51L2 (RAD51C) protein and its requirement for gene conversion. J Biol Chem 278: 45445-45450.
23. Levenga J, Buijsen RA, Rife M, Moine H, Nelson DL, et al. (2009) Ultrastructural analysis of the functional domains in FMRP using primary hippocampal mouse neurons. Neurobiol Dis 35: 241-250.